Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma

BACKGROUND: Tisagenlecleucel demonstrated a high rate of durable response in adult patients with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL) in the pivotal global phase 2 JULIET study. Here, we report the efficacy and safety of tisagenlecleucel in the Japanese subgroup. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Hideki, Makita, Shinichi, Kato, Koji, Tokushige, Kota, Fujita, Taizo, Akashi, Koichi, Izutsu, Koji, Teshima, Takanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441082/
https://www.ncbi.nlm.nih.gov/pubmed/32448949
http://dx.doi.org/10.1007/s10147-020-01699-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441082/
https://www.ncbi.nlm.nih.gov/pubmed/32448949
http://dx.doi.org/10.1007/s10147-020-01699-6

Ejemplares similares